-
Can We Make Oxygen Out Of Thin (Martian) Air? MIT's Michael Hecht Has The MOXIE To Try
MOXIE is one of seven scientific instruments aboard NASA's Perseverance rover. -
Perseverance's Search For Life On Mars Could 'Answer All Our Dreams,' Says MIT Geobiologist
Tanja Bosak, a scientist on the Perseverance team, discusses the potential for life on Mars. -
'The Sky's Not Even The Limit': Cancer Survivor To Become Youngest American In Space
Hayley Arceneaux, 29, became a physician's assistant at St. Jude Children's Research Hospital nearly a year ago, almost two decades after beating… -
Long-Term Studies Of COVID-19 Vaccines Hurt By Placebo Recipients Getting Immunized
Researchers are trying to learn more about COVID-19 vaccines from original study participants. The quest is hampered because many people who first received a placebo shot are opting for the vaccine. -
How Herd Immunity Works — And What Stands In Its Way
What will it take to finally halt the spread of the coronavirus in the U.S.? To answer that question we've created a simulation of a mock disease we're… -
New Theory Suggests Dinosaur-Killing Impact Came From Edge Of Solar System
For decades, the prevailing theory about the extinction of the dinosaurs was that an asteroid from the belt between Mars and Jupiter slammed into the… -
A Rocky Road On The Way To Herd Immunity For COVID-19
At least 70% of people will need to be immune from the coronavirus before COVID-19 can recede through a process known as herd immunity. Vaccines can play a role. But reaching the goal won't be easy. -
David Pogue Previews NOVA's 'Beyond The Elements': 'We’re Not Kidding Around With The Danger Element'
In the new miniseries, Pogue sets out to understand how molecules and chemical reactions have transformed human life. -
Local Physicist Makes Case For Possible Alien Life
Harvard theoretical physicist Avi Loeb is out with a new book on Oumuamua. -
Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19
The vaccine did better at preventing disease in this country – 72% percent — and less well in South Africa – 57% efficacy. The efficacy seen in Latin America was 66%.
